Publication | Closed Access
Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions
15
Citations
2
References
2009
Year
Pharmaceutical ScienceValsartan 160-Mg TabletsBioequivalenceMedicineHealthy VolunteersPharmacotherapyPharmacologyPharmacokinetics
| Year | Citations | |
|---|---|---|
1983 | 410 | |
2002 | 21 |
Page 1
Page 1